Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$915M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$576M |
| 3 |
NVIDIA
NVDA
|
+$355M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$321M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$991M |
| 2 |
Cigna
CI
|
+$435M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$432M |
| 4 |
Medtronic
MDT
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 10.89% |
| 3 | Healthcare | 10.04% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
3751
DELISTED
Mersana Therapeutics
MRSN
| $95.1K | ﹤0.01% |
+1,640
| New | +$66K |
|
3752
GrowGeneration
GRWG
$88.9M
| $92.5K | ﹤0.01% |
36,854
-12,489
| -25% | -$30.6K |
|
|
SHCR
3753
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $91.7K | ﹤0.01% |
+84,864
| New | +$87K |
|
|
TVRD
3754
Tvardi Therapeutics
TVRD
$18.8M
| $87.3K | ﹤0.01% |
3,263
-851
| -21% | -$35.2K |
|
|
JMIA
3755
Jumia Technologies
JMIA
$727M
| $86.8K | ﹤0.01% |
24,578
+4,732
| +24% | +$14.2K |
|
|
SVM
3756
Silvercorp Metals
SVM
$2.39B
| $86.4K | ﹤0.01% |
32,855
-2,120
| -6% | -$5.19K |
|
3757
CEMIG Preferred Shares
CIG
$6.12B
| $85K | ﹤0.01% |
47,501
-990
| -2% | -$1.79K |
|
3758
Ardelyx
ARDX
$1.21B
| $84.4K | ﹤0.01% |
13,612
-954,263
| -99% | -$4.28M |
|
|
TSP
3759
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $84K | ﹤0.01% |
95,690
+74,761
| +357% | +$76.4K |
|
3760
Community Health Systems
CYH
$416M
| $83.7K | ﹤0.01% |
26,750
-459,254
| -94% | -$1.24M |
|
3761
Copel
ELPC
$8.6B
| $80.4K | ﹤0.01% |
+10,222
| New | +$80.4K |
|
|
BKCC
3762
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $80.1K | ﹤0.01% |
20,691
+90
| +0.4% | +$328 |
|
3763
Yext
YEXT
$574M
| $78.9K | ﹤0.01% |
+13,400
| New | +$82.5K |
|
|
CUTR
3764
DELISTED
Cutera, Inc.
CUTR
| $78.7K | ﹤0.01% |
22,332
-3,790
| -15% | -$11.5K |
|
3765
Ambev
ABEV
$46.8B
| $77.5K | ﹤0.01% |
27,559
-1,263
| -4% | -$3.41K |
|
|
MTTR
3766
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $76.2K | ﹤0.01% |
28,312
-9,267
| -25% | -$22.3K |
|
|
TEF
3767
DELISTED
Telefonica
TEF
| $75.3K | ﹤0.01% |
18,724
-11,210
| -37% | -$45K |
|
3768
UWM Holdings
UWMC
$624M
| $74.6K | ﹤0.01% |
10,315
-31,137
| -75% | -$176K |
|
3769
Zevra Therapeutics
ZVRA
$622M
| $73.7K | ﹤0.01% |
+11,258
| New | +$52.7K |
|
|
OPI
3770
DELISTED
Office Properties Income Trust
OPI
| $73.3K | ﹤0.01% |
10,015
-8,420
| -46% | -$44.8K |
|
3771
Rush Street Interactive
RSI
$2.67B
| $72.4K | ﹤0.01% |
16,127
-3,400
| -17% | -$14.1K |
|
3772
ICL Group
ICL
$6.75B
| $69.8K | ﹤0.01% |
+13,932
| New | +$70.9K |
|
|
FT
3773
Franklin Universal Trust
FT
$198M
| $68.2K | ﹤0.01% |
10,259
-2
| -0% | -$13 |
|
3774
Aclaris Therapeutics
ACRS
$888M
| $68K | ﹤0.01% |
64,760
-12,755
| -16% | -$38.9K |
|
3775
Nkarta
NKTX
$157M
| $67.8K | ﹤0.01% |
10,276
-127
| -1% | -$329 |
|
Similar funds
Ameriprise's Q4 2023 Portfolio in Review
As of Q4 2023, Ameriprise held 4,040 positions worth $334B, up 9.7% from $305B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q4 2023 filing shows 156 new, 1,686 increased, 1,943 reduced and 146 closed positions. Its largest new stake was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M. The largest sale was Broadcom, an estimated $991M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2023 buy was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M.
- Ameriprise added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $915M increase.
- Ameriprise's biggest Q4 2023 reduction was Broadcom, cutting an estimated $991M.
- Ameriprise fully exited Activision Blizzard in Q4 2023, selling an estimated $374M.
- Ameriprise's ten largest holdings make up 17% of its $334B portfolio in Q4 2023.
- Ameriprise opened 156 new positions and closed 146 in Q4 2023.
- Ameriprise's portfolio value rose 9.7% quarter-over-quarter to $334B.
Based on Ameriprise's 13F filing for Q4 2023, filed 14 Feb 2024.